Published in J Neurol on March 01, 1997
Therapeutic drug monitoring of immunosuppressant drugs. Br J Clin Pharmacol (1999) 0.83
Azathioprine-Associated Complete NK Cell Deficiency. J Clin Immunol (2017) 0.75
Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci (2003) 3.38
Separate mechanisms activate sigma B of Bacillus subtilis in response to environmental and metabolic stresses. J Bacteriol (1995) 3.05
Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. Neurology (1999) 2.27
The Bacillus subtilis rsbU gene product is necessary for RsbX-dependent regulation of sigma B. J Bacteriol (1995) 2.00
Role of adenosine nucleotides in the regulation of a stress-response transcription factor in Bacillus subtilis. J Mol Biol (1996) 1.91
Overview of azathioprine treatment in multiple sclerosis. Lancet (1991) 1.83
Role of microvascular decompression in trigeminal neuralgia and multiple sclerosis. Lancet (1999) 1.76
Cloning, expression, and nucleotide sequence of genes involved in production of lactococcin DR, a bacteriocin from lactococcus lactis subsp. lactis. Appl Environ Microbiol (1994) 1.55
Characterization of the lacticin 481 operon: the Lactococcus lactis genes lctF, lctE, and lctG encode a putative ABC transporter involved in bacteriocin immunity. Appl Environ Microbiol (1997) 1.52
Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry (2001) 1.51
Trends in child overweight rates and energy intake in France from 1999 to 2007: relationships with socioeconomic status. Obesity (Silver Spring) (2009) 1.51
CSF T-cell subsets in multiple sclerosis: relationship to cerebrospinal fluid myelin basic protein and clinical activity. J Neurol (1989) 1.46
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis. Neurology (2010) 1.44
Continuous versus intermittent infusion of high-dose metoclopramide in prevention of cisplatin-induced emesis. Lancet (1992) 1.39
Estimating the distribution of usual dietary intake by short-term measurements. Eur J Clin Nutr (2002) 1.32
Clonotypic surface structure on human T lymphocytes: functional and biochemical analysis of the antigen receptor complex. Immunol Rev (1984) 1.24
Identification of recurring tumor-specific somatic mutations in acute myeloid leukemia by transcriptome sequencing. Leukemia (2011) 1.20
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology (2004) 1.20
Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests. Fundam Appl Toxicol (1993) 1.19
Dietary sources and correlates of sodium and potassium intakes in the French general population. Eur J Clin Nutr (2009) 1.18
Selective inhibition of interleukin 2 gene function following thymocyte antigen/major histocompatibility complex receptor crosslinking: possible thymic selection mechanism. Proc Natl Acad Sci U S A (1986) 1.16
Genomic 5-hydroxymethylcytosine levels correlate with TET2 mutations and a distinct global gene expression pattern in secondary acute myeloid leukemia. Leukemia (2011) 1.12
A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines. Development of a sandwich ELISA and in situ detection of producing cells. J Immunol Methods (1994) 1.12
Prevalence of primary headaches in people with multiple sclerosis. Cephalalgia (2004) 1.10
T3-Ti receptor triggering of T8+ suppressor T cells leads to unresponsiveness to interleukin-2. Nature (1984) 1.09
Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul Disord (2000) 1.09
A post-marketing study on interferon beta 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients. J Neurol Neurosurg Psychiatry (2003) 1.08
A motile but non-swarming mutant of Proteus mirabilis lacks FlgN, a facilitator of flagella filament assembly. Mol Microbiol (1997) 1.08
Bacterial swarming: a biochemical time-resolved FTIR-ATR study of Proteus mirabilis swarm-cell differentiation. Biochemistry (2001) 1.08
Endothelium and the brain in CNS lupus. Lupus (2003) 1.05
Prospective study of multiple sclerosis with early onset. Mult Scler (2002) 1.05
Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology (2011) 1.04
Murine monoclonal antibodies as probes for the phenotypical, functional, and molecular analysis of a discrete peripheral blood lymphocyte population exerting natural killer activity in vitro. Hum Immunol (1985) 1.03
Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cells. Hum Immunol (1984) 1.03
Asbestos stimulates IL-8 production from human lung epithelial cells. J Immunol (1994) 1.01
The effect of oxidase positive bacteria on total coliform density estimates. Health Lab Sci (1977) 1.01
Retracted Identification of a T helper cell-derived lymphokine that activates resting T lymphocytes. Science (1986) 1.00
The extrinsic/intrinsic classification of two-dimensional motion signals with barber-pole stimuli. Vision Res (1999) 0.99
Reactive oxygen species generated by glia are responsible for neuron death induced by human immunodeficiency virus-glycoprotein 120 in vitro. Neuroscience (2001) 0.98
Association of hepatitis B virus infection with other sexually transmitted infections in homosexual men. Omega Study Group. Am J Public Health (2000) 0.98
Headache in brain tumours: a symptom to reappraise critically. Neurol Sci (2004) 0.97
Human microvascular endothelial cells from different fetal organs demonstrate organ-specific CAM expression. Exp Cell Res (2005) 0.96
Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-alpha production. Inflamm Res (2002) 0.96
An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia. Leukemia (2011) 0.96
Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alpha. Toxicol Appl Pharmacol (1998) 0.96
Cycloheximide blocks the fall of plasma and tissue tryptophan levels after tryptophan-free amino acid mixtures. Life Sci (1991) 0.96
A small synthetic molecule capable of preferentially inhibiting the production of the CC chemokine monocyte chemotactic protein-1. Eur Cytokine Netw (1999) 0.96
Organotins induce apoptosis by disturbance of [Ca(2+)](i) and mitochondrial activity, causing oxidative stress and activation of caspases in rat thymocytes. Toxicol Appl Pharmacol (2000) 0.95
Thermal removal of nitrogen species from wood waste containing urea formaldehyde and melamine formaldehyde resins. J Hazard Mater (2008) 0.95
Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid beta-peptides induced oxidative stress and reduces NF-kappaB activation. Neurochem Int (2002) 0.95
Azathioprine. Safety profile in multiple sclerosis patients. Neurol Sci (2007) 0.93
Three years of experience: the Italian registry and safety data update. Neurol Sci (2011) 0.92
The human T-cell receptor. J Clin Immunol (1985) 0.92
Interferon treatment may trigger primary headaches in multiple sclerosis patients. Mult Scler (2006) 0.91
Oculomotor disturbances in Balint's syndrome: anatomoclinical findings and electrooculographic analysis in a case. Cortex (1982) 0.91
A double blind study on azathioprine efficacy in multiple sclerosis: final report. J Neurol (1993) 0.91
Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses. Eur Neurol (1994) 0.91
Immune parameters in biological monitoring of pesticide exposure: current knowledge and perspectives. Toxicol Lett (1999) 0.90
Lantibiotic biosynthesis: interactions between prelacticin 481 and its putative modification enzyme, LctM. J Bacteriol (2000) 0.90
Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term results. Neurol Sci (2007) 0.90
Confocal laser endomicroscopy in celiac disease: description of findings in two cases. Endoscopy (2007) 0.90
Immunocompetence of human microvascular brain endothelial cells: cytokine regulation of IL-1beta, MCP-1, IL-10, sICAM-1 and sVCAM-1. J Neurol (1998) 0.90
CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients. J Neurooncol (2005) 0.89
Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study. J Neurol Neurosurg Psychiatry (2009) 0.88
Temozolomide and cisplatin in the treatment of leptomeningeal metastatic involvement from melanoma: a case report. Neurol Sci (2002) 0.88
Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study. Mult Scler (2005) 0.88
Low serum interleukin-10 levels in multiple sclerosis: further evidence for decreased systemic immunosuppression? J Neurol (1996) 0.87
Immunoblotting on polyvinyldifluoride improves detection of oligoclonal IgG bands in CSF. Clin Chem (1987) 0.87
Low level exposure to chemicals and immune system. Toxicol Appl Pharmacol (2005) 0.87
Cyclophosphamide for multiple sclerosis. Cochrane Database Syst Rev (2007) 0.86
Anterior and non-anterior ruptured aneurysms: memory and frontal lobe function performance following coiling. Eur J Neurol (2005) 0.85
Cryptococcal meningoencephalitis: intrathecal immunological response. J Neurol (1986) 0.85
Retracted Clonal analysis of B cell growth and differentiation activities induced from T lymphocytes upon triggering of T3-Ti and T11 pathways. J Immunol (1985) 0.85
Human brain endothelial cells and astrocytes produce IL-1 beta but not IL-10. Scand J Immunol (1996) 0.84
Asbestos toxicity: an immunologic perspective. Rev Environ Health (1999) 0.84
Benzydamine inhibits the release of tumor necrosis factor-alpha and monocyte chemotactic protein-1 by Candida albicans-stimulated human peripheral blood cells. Int J Clin Lab Res (1997) 0.84
Chorea in Behçet's syndrome. J Neurol (1982) 0.84
Pentamidine: an inhibitor of interleukin-1 that acts via a post-translational event. Toxicol Appl Pharmacol (1991) 0.84
Italian version of the Chicago multiscale depression inventory: translation, adaptation and testing in people with multiple sclerosis. Neurol Sci (2004) 0.83
Inflammatory molecule release by beta-amyloid-treated T98G astrocytoma cells: role of prostaglandins and modulation by paracetamol. Eur J Pharmacol (1998) 0.83
Dying neural cells activate glia through the release of a protease product. Glia (2000) 0.83
Generation and characterization of murine monoclonal antibodies against HLA Class II molecules. Diagn Immunol (1984) 0.83
Inhibition of tumor necrosis factor-alpha (TNF-alpha)/TNF-alpha receptor binding by structural analogues of suramin. Biochem Pharmacol (1999) 0.83